Jacqueline Shirley Dron, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertriglyceridemia | 9 | 2022 | 293 | 3.210 |
Why?
|
Multifactorial Inheritance | 11 | 2023 | 1381 | 2.120 |
Why?
|
Triglycerides | 13 | 2024 | 2457 | 1.590 |
Why?
|
Dyslipidemias | 7 | 2024 | 870 | 1.580 |
Why?
|
Lipoprotein Lipase | 7 | 2022 | 133 | 1.260 |
Why?
|
DNA Copy Number Variations | 10 | 2021 | 2024 | 1.150 |
Why?
|
Hyperlipidemias | 3 | 2022 | 771 | 1.150 |
Why?
|
Lipoprotein(a) | 2 | 2021 | 482 | 0.980 |
Why?
|
Hyperlipoproteinemia Type I | 2 | 2022 | 11 | 0.930 |
Why?
|
Hyperlipidemia, Familial Combined | 2 | 2022 | 14 | 0.900 |
Why?
|
Receptors, Lipoprotein | 4 | 2020 | 88 | 0.880 |
Why?
|
Receptors, LDL | 3 | 2020 | 489 | 0.820 |
Why?
|
Genetic Variation | 6 | 2021 | 6565 | 0.810 |
Why?
|
Cholesterol, HDL | 7 | 2024 | 1812 | 0.800 |
Why?
|
Hyperlipoproteinemia Type II | 6 | 2024 | 395 | 0.760 |
Why?
|
Gene Deletion | 2 | 2019 | 2656 | 0.740 |
Why?
|
Cholesterol, LDL | 9 | 2024 | 2380 | 0.730 |
Why?
|
Atherosclerosis | 5 | 2024 | 3405 | 0.720 |
Why?
|
Genetic Predisposition to Disease | 15 | 2024 | 17889 | 0.710 |
Why?
|
Hypercholesterolemia | 4 | 2024 | 1141 | 0.670 |
Why?
|
Lipid Metabolism Disorders | 1 | 2019 | 20 | 0.650 |
Why?
|
Hypoalphalipoproteinemias | 1 | 2018 | 2 | 0.630 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2020 | 501 | 0.580 |
Why?
|
Apolipoproteins | 1 | 2019 | 327 | 0.550 |
Why?
|
Cholesterol | 4 | 2021 | 2902 | 0.540 |
Why?
|
Lipoproteins, LDL | 1 | 2020 | 643 | 0.540 |
Why?
|
Genotype | 4 | 2023 | 12983 | 0.520 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2020 | 3634 | 0.490 |
Why?
|
Lipoproteins, HDL | 1 | 2018 | 675 | 0.450 |
Why?
|
Arteries | 1 | 2018 | 1121 | 0.440 |
Why?
|
Genetic Testing | 3 | 2022 | 3536 | 0.420 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2024 | 15915 | 0.390 |
Why?
|
Coronary Disease | 2 | 2023 | 5921 | 0.380 |
Why?
|
Blood Coagulation | 1 | 2017 | 1156 | 0.380 |
Why?
|
Lipids | 3 | 2024 | 3330 | 0.370 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15513 | 0.360 |
Why?
|
Plaque, Atherosclerotic | 2 | 2018 | 1535 | 0.330 |
Why?
|
Genome-Wide Association Study | 9 | 2024 | 12670 | 0.320 |
Why?
|
Coronary Artery Disease | 5 | 2024 | 6504 | 0.270 |
Why?
|
Phenotype | 10 | 2024 | 16572 | 0.270 |
Why?
|
Brain Ischemia | 1 | 2019 | 3031 | 0.260 |
Why?
|
Apolipoprotein C-II | 3 | 2020 | 15 | 0.250 |
Why?
|
DNA | 4 | 2023 | 7189 | 0.230 |
Why?
|
Thrombosis | 1 | 2017 | 2944 | 0.220 |
Why?
|
Humans | 47 | 2024 | 761098 | 0.210 |
Why?
|
Mendelian Randomization Analysis | 2 | 2024 | 1010 | 0.190 |
Why?
|
Heterozygote | 4 | 2022 | 2778 | 0.190 |
Why?
|
MicroRNAs | 1 | 2017 | 3758 | 0.190 |
Why?
|
Penetrance | 1 | 2023 | 382 | 0.190 |
Why?
|
Apolipoproteins B | 1 | 2023 | 385 | 0.190 |
Why?
|
Scavenger Receptors, Class B | 1 | 2021 | 85 | 0.180 |
Why?
|
Computational Biology | 4 | 2019 | 3499 | 0.170 |
Why?
|
Subtilisins | 1 | 2020 | 79 | 0.170 |
Why?
|
Middle Aged | 19 | 2024 | 220835 | 0.160 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2019 | 77 | 0.160 |
Why?
|
Atrial Fibrillation | 3 | 2022 | 5115 | 0.150 |
Why?
|
Genetics, Medical | 1 | 2021 | 334 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2024 | 518 | 0.150 |
Why?
|
Risk Factors | 11 | 2024 | 74219 | 0.140 |
Why?
|
RNA, Transfer | 1 | 2019 | 279 | 0.140 |
Why?
|
Gene Duplication | 1 | 2018 | 314 | 0.140 |
Why?
|
Stroke | 1 | 2019 | 9720 | 0.140 |
Why?
|
Pancreatitis | 1 | 2024 | 1097 | 0.140 |
Why?
|
DNA Mutational Analysis | 3 | 2019 | 4109 | 0.130 |
Why?
|
Eicosapentaenoic Acid | 1 | 2019 | 561 | 0.130 |
Why?
|
Adult | 14 | 2024 | 221083 | 0.130 |
Why?
|
Bibliometrics | 1 | 2019 | 352 | 0.120 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2018 | 563 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 778 | 0.120 |
Why?
|
Female | 21 | 2024 | 392458 | 0.120 |
Why?
|
Male | 19 | 2024 | 360675 | 0.120 |
Why?
|
Metabolomics | 1 | 2024 | 1658 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1231 | 0.120 |
Why?
|
Oligopeptides | 1 | 2020 | 1178 | 0.120 |
Why?
|
Genetic Markers | 2 | 2017 | 2599 | 0.110 |
Why?
|
History, 21st Century | 1 | 2020 | 1566 | 0.110 |
Why?
|
Aged | 10 | 2024 | 169266 | 0.110 |
Why?
|
Risk Assessment | 5 | 2024 | 24013 | 0.110 |
Why?
|
Exons | 1 | 2019 | 2380 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1312 | 0.110 |
Why?
|
Peripheral Arterial Disease | 1 | 2024 | 1274 | 0.100 |
Why?
|
History, 20th Century | 1 | 2020 | 2764 | 0.100 |
Why?
|
Alcoholism | 1 | 2023 | 1973 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2011 | 0.090 |
Why?
|
Anticholesteremic Agents | 1 | 2018 | 968 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1868 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2024 | 3951 | 0.090 |
Why?
|
Gene Expression | 2 | 2019 | 7567 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2021 | 2021 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1049 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2731 | 0.070 |
Why?
|
Mutation | 4 | 2023 | 30006 | 0.070 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4243 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2223 | 0.060 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9518 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15845 | 0.060 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 67 | 0.060 |
Why?
|
Animals | 5 | 2021 | 168083 | 0.060 |
Why?
|
Apolipoprotein B-100 | 1 | 2024 | 157 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5754 | 0.060 |
Why?
|
Disease Progression | 1 | 2018 | 13506 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 54419 | 0.050 |
Why?
|
Cohort Studies | 2 | 2024 | 41486 | 0.040 |
Why?
|
Intention | 1 | 2023 | 347 | 0.040 |
Why?
|
Anticodon | 1 | 2019 | 24 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29672 | 0.040 |
Why?
|
COS Cells | 1 | 2021 | 1129 | 0.040 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2019 | 107 | 0.040 |
Why?
|
Glucuronosyltransferase | 1 | 2019 | 132 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18217 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11701 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2019 | 518 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1636 | 0.030 |
Why?
|
Perception | 1 | 2023 | 1198 | 0.030 |
Why?
|
Biological Transport | 1 | 2021 | 2082 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2113 | 0.030 |
Why?
|
Heredity | 1 | 2016 | 148 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2019 | 896 | 0.030 |
Why?
|
Ontario | 1 | 2016 | 398 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 1 | 2022 | 1559 | 0.030 |
Why?
|
Acute Disease | 1 | 2024 | 7240 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3582 | 0.030 |
Why?
|
Gene Dosage | 1 | 2016 | 1217 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3803 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3016 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2023 | 4028 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3899 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5413 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5828 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5520 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13254 | 0.020 |
Why?
|
Young Adult | 2 | 2024 | 59199 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3700 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6225 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2021 | 22157 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20120 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9478 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 29872 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15308 | 0.010 |
Why?
|
United States | 1 | 2022 | 72337 | 0.010 |
Why?
|
Child | 1 | 2019 | 80134 | 0.010 |
Why?
|